Charles Kunsch BS, PhD

Chuck has 25 years of experience in pharmaceutical R&D, Business Development and Venture Investments. Broad experience in sourcing, evaluation and transacting complex early-stage equity investments and business development partnerships through leveraging a well-established network of scientific and business professionals. Involvement on the Boards of several venture capital backed companies including Aquinnah Pharmaceutcals, Quentis Therapeutics, Ribometrix, Paragen Bio and Prevail Therapeutics.